RIYADH: The Kingdom’s Ministry of Health recently held an accelerator program in Boston to support the work of eight Saudi Arabia biotechnology and life sciences startups.
The first cohort of the program, carried out in partnership with BioLabs, had direct exposure to advanced global research and development environments, the ministry said in a statement.
It is a milestone in the Kingdom’s efforts to localize health innovation and strengthen its biotechnology and life sciences ecosystem, the ministry added.
The startups include Plansulin that is developing plant-based insulin, cellNUA offering nano-therapies derived from bees, SAGEbio focusing on next-generation vaccines, and Novo Genomics working on precision diagnostics.
In addition, MammoStem explores regenerative medicine, NanoPalm targets genetic disorders, KaRama Bio specializes in early disease detection, and PhageTech is working to combat antibiotic resistance.
